175 related articles for article (PubMed ID: 27997158)
1. Chaperone-like Activity of Calnuc Prevents Amyloid Aggregation.
Kanuru M; Aradhyam GK
Biochemistry; 2017 Jan; 56(1):149-159. PubMed ID: 27997158
[TBL] [Abstract][Full Text] [Related]
2. Chaperoning Against Amyloid Aggregation: Monitoring In Vitro and In Vivo.
Vignesh R; Aradhyam GK
Methods Mol Biol; 2019; 1929():135-154. PubMed ID: 30710272
[TBL] [Abstract][Full Text] [Related]
3. Calnuc binds to Alzheimer's beta-amyloid precursor protein and affects its biogenesis.
Lin P; Li F; Zhang YW; Huang H; Tong G; Farquhar MG; Xu H
J Neurochem; 2007 Mar; 100(6):1505-14. PubMed ID: 17348862
[TBL] [Abstract][Full Text] [Related]
4. Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization.
Bonito-Oliva A; Barbash S; Sakmar TP; Graham WV
Sci Rep; 2017 Feb; 7():42880. PubMed ID: 28220836
[TBL] [Abstract][Full Text] [Related]
5. Ion-binding properties of Calnuc, Ca2+ versus Mg2+--Calnuc adopts additional and unusual Ca2+-binding sites upon interaction with G-protein.
Kanuru M; Samuel JJ; Balivada LM; Aradhyam GK
FEBS J; 2009 May; 276(9):2529-46. PubMed ID: 19302560
[TBL] [Abstract][Full Text] [Related]
6. Serine protease activity of calnuc: regulation by Zn2+ and G proteins.
Kanuru M; Raman R; Aradhyam GK
J Biol Chem; 2013 Jan; 288(3):1762-73. PubMed ID: 23195954
[TBL] [Abstract][Full Text] [Related]
7. MAP2 prevents protein aggregation and facilitates reactivation of unfolded enzymes.
Sarkar T; Mitra G; Gupta S; Manna T; Poddar A; Panda D; Das KP; Bhattacharyya B
Eur J Biochem; 2004 Apr; 271(8):1488-96. PubMed ID: 15066174
[TBL] [Abstract][Full Text] [Related]
8. G Protein binding sites on Calnuc (nucleobindin 1) and NUCB2 (nucleobindin 2) define a new class of G(alpha)i-regulatory motifs.
Garcia-Marcos M; Kietrsunthorn PS; Wang H; Ghosh P; Farquhar MG
J Biol Chem; 2011 Aug; 286(32):28138-49. PubMed ID: 21653697
[TBL] [Abstract][Full Text] [Related]
9. The mammalian calcium-binding protein, nucleobindin (CALNUC), is a Golgi resident protein.
Lin P; Le-Niculescu H; Hofmeister R; McCaffery JM; Jin M; Hennemann H; McQuistan T; De Vries L; Farquhar MG
J Cell Biol; 1998 Jun; 141(7):1515-27. PubMed ID: 9647645
[TBL] [Abstract][Full Text] [Related]
10. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
Huang L; Liu X; Cheng B; Huang K
Arch Biochem Biophys; 2015 Feb; 568():46-55. PubMed ID: 25615529
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of protein homeostasis in health, aging and disease.
Goloubinoff P
Swiss Med Wkly; 2016; 146():w14306. PubMed ID: 27045704
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.
Rekas A; Adda CG; Andrew Aquilina J; Barnham KJ; Sunde M; Galatis D; Williamson NA; Masters CL; Anders RF; Robinson CV; Cappai R; Carver JA
J Mol Biol; 2004 Jul; 340(5):1167-83. PubMed ID: 15236975
[TBL] [Abstract][Full Text] [Related]
13. Process, Outcomes and Possible Elimination of Aggregation with Special Reference to Heme Proteins; Likely Remediations of Proteinopathies.
Furkan M; Khan RH
Curr Protein Pept Sci; 2020; 21(6):573-583. PubMed ID: 32013844
[TBL] [Abstract][Full Text] [Related]
14. Calnuc, an EF-hand Ca(2+) binding protein, specifically interacts with the C-terminal alpha5-helix of G(alpha)i3.
Lin P; Fischer T; Weiss T; Farquhar MG
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):674-9. PubMed ID: 10639138
[TBL] [Abstract][Full Text] [Related]
15. Chaperone-like activity revealed in the matricellular protein SPARC.
Emerson RO; Sage EH; Ghosh JG; Clark JI
J Cell Biochem; 2006 Jul; 98(4):701-5. PubMed ID: 16598771
[TBL] [Abstract][Full Text] [Related]
16. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
[TBL] [Abstract][Full Text] [Related]
17. The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of β-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes.
Chien V; Aitken JF; Zhang S; Buchanan CM; Hickey A; Brittain T; Cooper GJ; Loomes KM
Biochem J; 2010 Nov; 432(1):113-21. PubMed ID: 20735358
[TBL] [Abstract][Full Text] [Related]
18. Protein Misfolding Diseases.
Hartl FU
Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
[TBL] [Abstract][Full Text] [Related]
19. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
Chiti F; Dobson CM
Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
[TBL] [Abstract][Full Text] [Related]
20. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
